Average Co-Inventor Count = 3.92
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Wyeth (8 from 1,309 patents)
2. Jiangsu Hengrui Medicine Company Ltd. (3 from 159 patents)
3. Shanghai Hengrui Pharmaceutical Co., Ltd. (2 from 100 patents)
4. Jiangsu Hengrui Pharmaceuticals Co., Ltd. (5 patents)
11 patents:
1. 12187684 - Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof
2. 11512055 - Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereof
3. 10144737 - Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors
4. 7705030 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation
5. 7700602 - Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase
6. 7576087 - Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
7. 7560470 - Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
8. 7482349 - Amino-5,5-diphenylimidazolone derivatives for the inhibition of β-secretase
9. 7417047 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation
10. 7259165 - Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
11. 7238696 - Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands